Assembling intelligence…
IGF::OT::IGF AWARD OF PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES, IDIQ CONTRACT. PERIOD OF PERFORMANCE: DECEMBER 15, 2014 THROUGH DECEMBER 14, 2021.
| Company | Orders | Obligated | Latest order end |
|---|---|---|---|
| DYNPORT VACCINE COMPANY LLC | 13 | $15.9M | 2025-01-31 |
| 75N93022F00057 DYNPORT VACCINE COMPANY LLC · National Institutes of Health | $5.2M | 2024-12-15 |
| 75N93021F00202 DYNPORT VACCINE COMPANY LLC · National Institutes of Health | $4.1M | 2025-01-31 |
| HHSN27200006 DYNPORT VACCINE COMPANY LLC · National Institutes of Health | $3.9M | 2020-11-07 |
| HHSN27200003 DYNPORT VACCINE COMPANY LLC · National Institutes of Health | $1.8M | 2023-08-30 |
| HHSN27200005 DYNPORT VACCINE COMPANY LLC · National Institutes of Health | $216K | 2022-05-31 |